Skip to main content
. 2023 Jul 25;11:122. doi: 10.1186/s40478-023-01615-9

Table 1.

Summary of meningioma cases included across all papers

Meningioma Cases (n,%)
Original Cohort Included Cohort H3K27me3 Retained H3K27me3 Ambiguous H3K27me3 Lost
Ammendola et al. 39 34 (87.2)* 27 (69.2) 0 (-) 7 (18.0)
Behling et al. 1347 1268 (94.1)* 1208 (95.2) 0 (-) 60 (4.7)
Gauchotte et al. 66 47 (71.2)* 37 (78.7) 0 (-) 10 (21.3)
Hua et al. [14] 192 192 (100) 160 (83.3) 0 (-) 32 (16.7)
Hua et al. [13] 164 164 (100) 81 (49.4) 0 (-) 83 (50.6)
Jung et al. 468 141 (30.1)* 93 (66.0) 0 (-) 48 (34.0)
Katz et al. 232 232 (100) 194 (83.6) 13 (5.6) 25 (10.8)
Nassiri et al. 181 151 (83.4)* 119 (78.8) 11 (7.3) 21 (13.9)
Samal et al. 149 147 (98.7)* 128 (87.1) 13 (8.8)a 6 (4.1)
Total 2811 2376 (84.5) 2047 (86.1) 37 (1.6) 292 (12.3)

*Reason for exclusion: inconclusive or technically unsatisfactory staining, Reason for exclusion: age of meningioma tissue, Classified as H3K27me3 retained for analysis, aCases were unused in analysis